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Introduction
The tension-free vaginal tape (TVT) procedure, described
by Ulmsten and Petros [1] in 1995, is a safe and effective
treatment for stress urinary incontinence (SUI), offer-
ing the benefits of a minimally invasive technique with
superior long-term results [2]. However, because the
TVT is introduced paraurethrally using a 5 × 100 mm
trocar, organs and tissues near the passage of the trocar
are vulnerable to injury [3]. The suprapubic arc sling
(SPARC) procedure was developed to utilize the poste-
rior surface of the pubic symphysis as a tactile guide for
the downward passage of a finer, longer needle (3 ×
220 mm) in an effort to decrease bowel, lower urinary
tract and vascular injuries that occasionally occurred
with the upward passage of the TVT trocar [4,5]. In
2001, Delorme [6] described a new surgical approach
in which the needle passage avoids the retropubic space
by passing the sling through the obturator foramen.
This theoretically minimizes the risk of vascular, bladder
and bowel injury during passage of the needle. Since
then, transobturator suburethral tape (MONARC) pro-
cedures have been shown to be a safe and effective
treatment for SUI, offering the benefits of a minimally
invasive technique with effective long-term results [7–9].
Differences in the mode of insertion and the angle
of the sling may influence the outcomes, even if the
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materials and biomechanical properties appear similar.
We designed this study to compare the clinical outcomes
of the SPARC and MONARC (American Medical System,
Minnetonka, MN, USA) procedures for the surgical
treatment of SUI in women. In this study, we aimed to
assess the differences in the approaches that may affect
the cure rate and postoperative voiding functions.
Materials and Methods
From September 1, 2003 through August 22, 2005, 115
consecutive patients with SUI underwent surgery at
our hospital for the placement of a suburethral sling.
During the first part of the study period (September
2003–February 2004), we performed the SPARC pro-
cedure in 35 patients. MONARC was subsequently intro-
duced to Taiwan, because the available clinical data
indicated that the MONARC approach was more min-
imally invasive with comparable results [7–9]; our group
then performed the MONARC approach in 80 patients
between March 2004 and August 2005. Intraoperative
and postoperative complications, cure rates, and patient
satisfaction rates for SPARC and MONARC performed
nonconcurrently were then retrospectively compared.
Since SPARC was the first technique used, the follow-
up times and observation times for the SPARC group
were longer than those for the MONARC group.
All patients who required SUI treatment were candi-
dates for this study. Patients with detrusor overreactivity,
previous failed incontinence surgery or loss of follow-
up were excluded. Preoperative evaluations included
detailed history, physical examination, Q-tip test, cough
stress test, and 1-hour pad test; preoperative urodynamic
studies included uroflowmetry, static and dynamic ure-
thral pressure profiles, urethrocystometry, and post-void
residual (PVR) measured using a catheter.
Postoperative follow-up visits were scheduled at 
1 week and 1, 3, 6, 12 and 24 months. Charts pro-
duced from the study were reviewed both subjectively
and objectively, including the need for medication 
for urgency, urinary retention and other perioperative
complications.
Uroflowmetry, PVR, 1-hour pad test, and cough
provocation tests were performed postoperatively at 
3 to 6 months in all patients. Patients were: “objectively
cured” when they had both negative cough stress test
and dry pad test results; “objectively improved” when
they had improved SUI, a positive stress test result and
a > 50% reduction of pad weight from preoperative val-
ues; and “objectively failed” for the remaining patients.
Subjective outcomes were collected by an experienced
nurse. At the most recent telephone interview in January
2006, the mean follow-up period was 13.1 months for
the MONARC group and 23.9 months for the SPARC
group. Since the follow-up period was long, all answers
from the telephone interviews were based on the patients’
own perceptions. The patients were questioned on per-
sistent SUI, voiding difficulties, and urgent need to
empty the bladder (i.e. urgency). “Subjectively cured”
was defined as an absence of complaints of urine leak-
age and “subjectively improved” defined as a > 50% de-
crease in the number of SUI episodes. The rest of the
patients were considered as “subjectively failed”. Patients
were also asked to rate their overall satisfaction on the
surgical outcomes as “satisfied”, “moderately satisfied”,
“not very satisfied” or “not at all satisfied”.
All cases were operated on under general anesthe-
sia by a surgeon and all received preoperative broad-
spectrum intravenous antibiotics. The same surgeon was
used to avoid inter-surgeon variations or differences in
operating procedures.
The SPARC procedure was performed as described
by Deval et al [10]. Cystoscopy was performed to ver-
ify the absence of bladder injury. The plastic sheath
covering the Prolene tape remained until the tape was
correctly adjusted without tension, leaving a 3–5 mm
space between the urethra and the mesh. The MONARC
procedure was performed as described by Dargent 
et al [11] with the patient in a high lithotomy position.
A Kelly clamp was placed between the urethra and
mesh for tension adjustment, leaving a 3–5 mm space
between the urethra and the mesh. In both SPARC and
MONARC patients, the vaginal incision was closed with
interrupted sutures of resorbable thread. A urinary
catheter was inserted in the bladder and was removed
the day following surgery, and PVR was measured before
the patient was discharged from the hospital. In case
of voiding difficulties, hospitalization was prolonged
until a PVR of less than 100 mL was obtained.
Patients were classified as having postoperative void-
ing difficulties if they were experiencing hesitancy in
voiding, weak stream, or discontinuous flow and/or
residual urine of more than 100 mL.
Postoperative urinary tract infection was assessed
at the 1-week postoperative follow-up visit. Urinary tract
infection was defined as having bacteriuria (>105 colony-
forming units/mL of urine) or a white blood cell count
of 75 per high-power field in the urine analysis. None
of the subjects involved in this study had infections
before their operations. Statistical analysis was per-
formed using Student’s t test for parametric and non-
parametric continuous variables, and Wilcoxon signed
rank test or McNemar test for categorical variables. 
A p value of less than 0.05 was considered statistically
significant.
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Results
Of the 35 patients who underwent the SPARC procedure,
three patients were excluded because of loss to follow-
up; of the 80 patients who underwent the MONARC
procedure, six patients were excluded because of loss to
follow-up. There were no significant differences between
the groups with respect to age, parity, body mass index,
concomitant reconstructive procedure, and ratio of in-
trinsic sphincter deficiency (Table 1). The SPARC patients
had significantly longer operation times and length of
hospital stay. There were no statistically significant dif-
ferences between the two groups in terms of perioper-
ative and postoperative complications (Table 2), except
for de novo urgency or frequency, which was more com-
mon in the SPARC group (25% vs. 2.7%; p = 0.001). The
“obstructive” effects decreased to 12.5% at the 3-month
follow-up visit and the last telephone interview found
that only 9.7% of the SPARC patients still exhibited
symptoms. A total of 8.1% of the MONARC patients
had de novo urgency at the 3- to 4-month follow-up visit;
however, at the last telephone interview, only 1.4% still
showed symptoms. There were trends towards fewer
symptoms of voiding difficulty after the MONARC pro-
cedure at the 3-month visit (20.3% vs. 31.3%; p = 0.222)
and at the last telephone interview (1.4% vs. 9.4%; p =
0.081). Postoperative urinary tract infection was more
common in the MONARC group (23.0% vs. 6.3%; p =
0.053). No bladder perforations, hemorrhages or vagi-
nal erosions were apparent in either group. The preop-
erative and postoperative uroflowmetry evaluation for
the MONARC and SPARC groups did not reveal any
statistically significant differences (Table 3).
Table 4 demonstrates the objective and subjective
surgical outcomes of the two groups; the majority of
patients were cured. Objective cure rates were com-
pared at 3–6 months postoperatively and were not 
significantly different between the groups (MONARC
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Table 1. Characteristics of female patients undergoing the suprapubic arc sling (SPARC) versus the transobturator suburethal
tape (MONARC) procedures in stress urinary incontinence treatment*
Characteristics MONARC (n = 74) SPARC (n = 32) p†
Age (yr) 54.1 ± 11.7 57.9 ± 11.3 0.117
Parity 3.5 ± 1.2 3.9 ± 1.5 0.141
Menopause status 38.0 (51.4) 21.0 (66) 0.174
Body mass index (kg/m2) 25.5 ± 3.7 25.0 ± 3.1 0.483
Concomitant reconstructive procedure‡ 52.0 (70.3) 24.0 (75) 0.162
Intrinsic sphincter deficiency§ 17.0 (23) 5.0 (15.6) 0.414
Mean operative time (min) 93.1 128.6 0.000
Anti-incontinence operation alone (min) 28.2 ± 19.6 (n = 14) 25.0 ± 21.2 (n = 2) 0.872
With concomitant operation (min) 74.2 ± 30.8 100.40 ± 27.3 0.000
Length of hospital stay (d) 4.3 ± 1.5 5.0 ± 1.3 0.012
Length of follow-up (mo) 13.1 ± 4.5 23.9 ± 2.2 0.000
*Data are presented as mean ± standard deviation or n (%); †p value using Chi-square test or Fisher’s exact test; ‡vaginal total hysterectomy, vaginal anterior
repair, vaginal posterior repair, enterocele repair, sacrospinous ligament fixation, uterine suspension; §maximal urethral closure pressure of less than 30 cmH2O.
Table 2. Effect of the suprapubic arc sling (SPARC) versus the transobturator suburethral tape (MONARC) procedures on 
the operative and postoperative complications in stress urinary incontinence treatment of female patients*
Complication MONARC (n = 74) SPARC (n = 32) p†
Bladder perforation 0 (0) 0 (0) –
Hemorrhage or hematoma 0 (0) 0 (0) –
Postoperative urinary retention (residual urine, > 100 mL) 6 (8.1) 3 (9.4) 1.000
Voiding difficulty (OPD F/U at 3–6 months) 15 (20.3) 10 (31.3) 0.222
Voiding difficulty (telephone interview) 1 (1.4) 3 (9.4) 0.081
Fever (temperature, > 38°C) 0 (0) 1 (3.1) 0.302
Urinary infection 17 (23) 2 (6.3) 0.053
De novo urgency/frequency 2 (2.7) 8 (25.0) 0.001
De novo urgency/frequency (OPD F/U) 6 (8.1) 4 (12.5) 0.485
De novo urgency/frequency (telephone interview) 1 (1.4) 3 (9.7) 0.081
Vaginal or urethral erosion 0 (0) 0 (0) –
*Data are presented as n (%); †Chi-squared test or Fisher’s exact test. OPD F/U = outpatient department follow-up.
80.6% vs. SPARC 90.6%; p = 0.258). There were differ-
ences, however, in the subjective outcomes evaluated at
the time of the last postoperative telephone interview
(both after more than 1 year of follow-up), with the
MONARC group having a significantly higher subjective
cure rate (97.3% vs. 77.4%; p < 0.05).
Discussion
The introduction of the retropubic suburethral sling has
made a significant impact on the surgical treatments
available for the management of SUI as compared with
the traditional colposuspension [12]. These tension-
free slings have equal efficacy in treating SUI, but the
MONARC involves a shorter operating time and lower
morbidity rate [13].
Cure rates of 85% have been reported using strict
objective and subjective outcome measures, with another
5–10% of patients showing significant improvement
[14]. A preliminary analysis of 7-year follow-up results
showed a cure rate of 81% [15].
New surgical techniques for SUI also aim to reduce
the potential obstructive effects without adversely af-
fecting cure rates. Most researchers found that dif-
ferent techniques were equally efficacious, but fewer
postoperative voiding difficulties were noted using the
transobturator route [7,9,16,17]. Our study demon-
strated that the SPARC group had a higher objective
cure rate than the MONARC group (90.6% vs. 80.6%)
at the 3- to 4-month postoperative evaluations, but the
difference was not statistically significant (p = 0.258).
When evaluating subjective cure rates at more than 
1 year after the operations using telephone interviews,
the MONARC group had higher subjective cure rate
(97.3% vs. 77.4%) and satisfaction rate (97.3% vs. 77.4%)
than the SPARC group. The higher postoperative uri-
nary retention rate and de novo urgency rate of SPARC
might be related to the differences described above,
although the results did not reach a significant level.
A study by Ansquer et al [7] compared the retropubic
and the obturator approaches. The patients in the retro-
pubic group had significantly more postoperative void-
ing difficulties than the obturator group (40% vs. 8%).
The results of the study by deTayrac et al [9] confirmed
this, showing a postoperative urinary retention rate of
25.8% in the TVT group and 13.3% in the MONARC
group (p > 0.05). Additionally, in the study by Davila 
et al [18] on the MONARC procedure, they identified
urinary retention in just 0.9% of the patients at 26 weeks
after surgery. In our study, no significant difference in
postoperative immediate urinary retention was found
at the 3- to 4-month evaluation (MONARC 8.1% vs.
SPARC 9.4%; p = 1.000).
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Table 3. Effect of the suprapubic arc sling (SPARC) versus the transobturator suburethral tape (MONARC) procedures on 
preoperative and postoperative uroflowmetry in stress urinary incontinence treatment of female patients*
MONARC (n = 74) SPARC (n = 32) p†
Preoperative
Qmax (mL/s) 19.4 ± 9.7 20.9 ± 11.1 0.523
Qave (mL/s) 10.3 ± 5.4 9.4 ± 4.7 0.399
Postoperative
Qmax (mL/s) 19.7 ± 8.6 20.4 ± 9.9 0.729
Qave (mL/s) 11.4 ± 13.8 9.6 ± 9.6 0.475
Post-void residual urine 40.6 ± 84.5 29.4 ± 54.5 0.495
*Data are presented as mean ± standard deviation; †Chi-squared test or Fisher’s exact test. Qmax = maximum urinary flow rate; Qave = average urinary flow rate.
Table 4. Effect of the suprapubic arc sling (SPARC) versus the transobturator suburethral tape (MONARC) procedures on the 
objective and subjective surgical outcomes in stress urinary incontinence treatment of female patients*
MONARC (n = 74) SPARC (n = 32) p†
Objective
Cured 58 (80.60) 29 (90.60) 0.258
Subjective
Cured 72 (97.30) 24 (77.40) < 0.05
Improved 1 (1.35) 7 (22.60)
Failed 1 (1.35) 0 (0)
*Data are presented as n (%); †Chi-squared test or Fisher’s exact test.
In the study by Wang et al [16], the SPARC group
had more incidences of postoperative frequency and
urgency than the MONARC group (10.3% vs. 9.7%; p =
0.706); this difference, however, was not statistically
significant.
deTayrac et al [9] reported no difference in the inci-
dence of de novo urgency between the MONARC (6.7%)
and TVT (6.6%) groups. Similar results were obtained
by Ansquer et al [7] (retropubic 4% vs. MONARC 4%).
In our current study, however, postoperative imme-
diate de novo urgency was significantly higher in the
SPARC group compared with the MONARC group (25%
vs. 2.7%; p = 0.001). The “obstructive” effects from tis-
sue reactions seem to diminish over time; at the 1-year
follow-up evaluations, rates were reduced to 9.7% in
the SPARC group and 1.4% in the MONARC group (p =
0.081). There were no bladder, vascular or bowel injuries
noted in either the MONARC group or SPARC group
in our current study.
In this study, the mean operative time was longer
with the SPARC procedure (100.4 vs. 74.2 minutes;
p = 0.00), possibly owing to the need for a cystoscopy in
the SPARC procedure. Moreover, the length of hospi-
tal stay was also longer in the SPARC group; it may be
partly because of the higher incidence rates of urinary
retention and de novo urgency found in this group.
The fact that patients involved in this study were
not randomized may be potentially limiting; it is, how-
ever, still interesting to compare the efficacy and rate
of complications between the two groups.
In conclusion, both MONARC and SPARC pro-
cedures are effective and safe surgical procedures for 
the treatment of female SUI. However, patients in the
MONARC group showed higher subjective cure and
satisfaction rates and less postoperative de novo urgency
than those in the SPARC group at more than 1 year of
follow-up. Cystoscopy is not required in the MONARC
technique, which is easier to perform. In addition, blad-
der and vascular injuries can be avoided, because the
treatment does not enter the retropubic space. The
MONARC approach could be considered as a preferred
choice given its low morbidity rate and high patient
satisfaction.
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